NOAC (Novel Oral Anticoagulants) and DOAC (Direct Oral Anticoagulants) are both types of anticoagulant medications that are used to help reduce the risk of stroke and other blood clot-related conditions. Both types of medications work by inhibiting the action of certain proteins in the blood that are involved in clotting.
The main difference between NOAC and DOAC is their mechanism of action. NOACs work by inhibiting two different proteins in the blood, whereas DOACs work by inhibiting only one protein. This difference is significant because it means that NOACs are more effective at reducing the risk of stroke and other blood clot-related conditions than DOACs.
In terms of side effects, there is no significant difference between NOACs and DOACs. Both medications can cause bleeding, nausea, and dizziness. However, NOACs may have fewer side effects than DOACs because they are more targeted in their action.
In addition, there is a difference in cost between NOACs and DOACs. NOACs are generally more expensive than DOACs, however, they are typically more effective and have fewer side effects.
Overall, both NOACs and DOACs are effective medications for reducing the risk of stroke and other blood clot-related conditions. The main difference between them is their mechanism of action, with NOACs being more targeted and effective, although more expensive, than DOACs.